| Pharmaceutical Information |
| Drug Name |
Hydroxocobalamin acetate |
| Drug ID |
BADD_D01100 |
| Description |
Hydroxocobalamin, also known as vitamin B12a and hydroxycobalamin, is an injectable form of vitamin B 12 that has been used therapeutically to treat vitamin B 12 deficiency. It is also used in cyanide poisoning, Leber's optic atrophy, and toxic amblyopia. |
| Indications and Usage |
For treatment of pernicious anemia and the prevention and treatment of vitamin B12 deficiency arising from alcoholism, malabsorption, tapeworm infestation, celiac, hyperthyroidism, hepatic-biliary tract disease, persistent diarrhea, ileal resection, pancreatic cancer, renal disease, prolonged stress, vegan diets, macrobiotic diets or other restrictive diets. Also for the treatment of known or suspected cyanide poisoning. |
| Marketing Status |
approved |
| ATC Code |
B03BA03; V03AB33 |
| DrugBank ID |
DB00200
|
| KEGG ID |
D02707
|
| MeSH ID |
D006879
|
| PubChem ID |
70689311
|
| TTD Drug ID |
D0VF4H
|
| NDC Product Code |
64552-4006; 82298-920; 61281-9700; 50396-7900 |
| UNII |
S535M27N3Q
|
| Synonyms |
Hydroxocobalamin | Hydroxo-Cobalamin | Hydroxycobalamin |
|
| Chemical Information |
| Molecular Formula |
C62H90CoN13O15P |
| CAS Registry Number |
13422-51-0 |
| SMILES |
CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=
N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C
)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co+2] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
